{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:56:02Z","timestamp":1790988962284,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.actbio.2013.09.022","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T03:31:40Z","timestamp":1380252700000},"page":"126-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-\u03b5-caprolactone matrix"],"prefix":"10.1016","volume":"10","author":[{"given":"Yongchun","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihui","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bifei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2013.09.022_b0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/IAE.0b013e31821e1f7c","article-title":"Further characterization of ocular safety profile of commercially available preserved and preservative-free triamcinolone acetonide","volume":"32","author":"Li","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2013.09.022_b0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2007.06.004","article-title":"Triamcinolone acetonide in ocular therapeutics","volume":"52","author":"Jermak","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.actbio.2013.09.022_b0215","doi-asserted-by":"crossref","first-page":"1916.e1911","DOI":"10.1016\/j.ophtha.2005.06.009","article-title":"Outcome of intravitreal triamcinolone in uveitis","volume":"112","author":"Kok","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2013.09.022_b0020","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1097\/IAE.0b013e31822a042a","article-title":"Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema","volume":"31","author":"Elbendary","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2013.09.022_b0025","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1038\/eye.2008.429","article-title":"Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion","volume":"23","author":"Wu","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.actbio.2013.09.022_b0030","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/IAE.0b013e31820d58f2","article-title":"Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial","volume":"31","author":"Ahmadieh","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2013.09.022_b0035","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol Chic"},{"key":"10.1016\/j.actbio.2013.09.022_b0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/IAE.0b013e318163194c","article-title":"ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema","volume":"28","author":"Kim","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2013.09.022_b0045","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch Ophthalmol Chic"},{"key":"10.1016\/j.actbio.2013.09.022_b0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-8-5","article-title":"Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema","volume":"8","author":"Cellini","year":"2008","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.actbio.2013.09.022_b0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/IJG.0b013e31802d696f","article-title":"Frequency and risk factors for intraocular pressure elevation after posterior sub-tenon capsule triamcinolone acetonide injection","volume":"16","author":"Iwao","year":"2007","journal-title":"J Glaucoma"},{"key":"10.1016\/j.actbio.2013.09.022_b0060","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ophtha.2010.03.033","article-title":"Intraocular and systemic pharmacokinetics of triamcinolone acetonide after a single 40-mg posterior subtenon application","volume":"117","author":"Shen","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2013.09.022_b0065","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1097\/IAE.0b013e31824fd384","article-title":"Comparison of intraocular pressure elevation after anterior versus posterior subtenon triamcinolone acetonide acetate injection: a retrospective study","volume":"32","author":"Liu","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2013.09.022_b0070","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ophtha.2009.01.039","article-title":"Triamcinolone acetonide concentration of aqueous humor after decanted 20-mg intravitreal injection","volume":"116","author":"Cheng","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2013.09.022_b0075","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2013.09.022_b0080","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1167\/iovs.09-4742","article-title":"Morphologic changes in the outflow pathways of bovine eyes treated with corticosteroids","volume":"51","author":"Tektas","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2013.09.022_b0085","article-title":"Anterior subtenon\u2019s triamcinolone acetonide (ASTTA) injection for the treatment of diabetic macular edem: animal and clinical findings","volume":"46","author":"Csaky","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2013.09.022_b0090","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.ophtha.2007.02.010","article-title":"Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study","volume":"114","author":"Chew","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2013.09.022_b0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/IAE.0b013e3181f049a8","article-title":"Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema","volume":"31","author":"Chew","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.actbio.2013.09.022_b0100","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/bjo.2009.172106","article-title":"Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-tenon injection","volume":"94","author":"Nan","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.actbio.2013.09.022_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.actbio.2013.09.022_b0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1167\/iovs.01-1156","article-title":"Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres","volume":"44","author":"Carrasquillo","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2013.09.022_b0115","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2013.09.022_b0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2008.04.023","article-title":"A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide","volume":"70","author":"Kim","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.actbio.2013.09.022_b0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2006.05.053","article-title":"Biodegradable scleral implants as new triamcinolone acetonide delivery systems","volume":"322","author":"Felt-Baeyens","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1016\/j.actbio.2013.09.022_b0130","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1205\/cherd06217","article-title":"Control of the domain microstructures of PLGA and PCL binary systems: importance of morphology in controlled drug release","volume":"85","author":"Tang","year":"2007","journal-title":"Chem Eng Res Des"},{"key":"10.1016\/j.actbio.2013.09.022_b0135","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1016\/j.biomaterials.2004.01.066","article-title":"The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis","volume":"25","author":"Sung","year":"2004","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2013.09.022_b0140","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0142-9612(00)00047-8","article-title":"In vitro and in vivo degradation of porous poly(dl-lactic-co-glycolic acid) foams","volume":"21","author":"Lu","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2013.09.022_b0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/bm010168s","article-title":"Enzymatic degradation of block copolymers prepared from epsilon-caprolactone and poly(ethylene glycol)","volume":"3","author":"Li","year":"2002","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2013.09.022_b0150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/1521-3935(200207)203:10\/11<1357::AID-MACP1357>3.0.CO;2-R","article-title":"Heterogeneous biodegradation of polycaprolactone \u2013 low molecular weight products and surface changes","volume":"203","author":"Hakkarainen","year":"2002","journal-title":"Macromol Chem Phys"},{"key":"10.1016\/j.actbio.2013.09.022_b0155","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/dmd.110.037408","article-title":"Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids","volume":"39","author":"Thakur","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.actbio.2013.09.022_b0160","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1167\/iovs.10-6233","article-title":"Sclera-choroid-RPE transport of eight beta-blockers in human, bovine, porcine, rabbit, and rat models","volume":"52","author":"Kadam","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2013.09.022_b0165","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00417-011-1694-9","article-title":"Subconjunctival sirolimus in the treatment of diabetic macular edema","volume":"249","author":"Krishnadev","year":"2011","journal-title":"Graef Arch Clin Exp"},{"key":"10.1016\/j.actbio.2013.09.022_b0170","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1167\/iovs.06-0954","article-title":"Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry","volume":"48","author":"Ghate","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.actbio.2013.09.022_b0175","first-page":"39","article-title":"Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon\u2019s injection","volume":"153","author":"Kovacs","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.actbio.2013.09.022_b0180","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/jop.2006.22.362","article-title":"The effect of recombinant human hyaluronidase on dexamethasone penetration into the posterior segment of the eye after sub-tenon\u2019s injection","volume":"22","author":"Kozak","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.actbio.2013.09.022_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.01.044","article-title":"Poly-epsilon-caprolactone microspheres and nanospheres: an overview","volume":"278","author":"Sinha","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.actbio.2013.09.022_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0039-128X(00)00235-X","article-title":"Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids","volume":"66","author":"Jaffuel","year":"2001","journal-title":"Steroids"},{"key":"10.1016\/j.actbio.2013.09.022_b0195","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ophtha.2010.12.028","article-title":"Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.actbio.2013.09.022_b0200","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone itravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2013.09.022_b0205","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archopht.1997.01100160559005","article-title":"Ganciclovir implant exchange \u2013 timing, surgical procedure, and complications","volume":"115","author":"Martin","year":"1997","journal-title":"Arch Ophthalmol Chic"},{"key":"10.1016\/j.actbio.2013.09.022_b0210","doi-asserted-by":"crossref","first-page":"e22507","DOI":"10.1371\/journal.pone.0022507","article-title":"Biocompatibility and biodegradation studies of subconjunctival implants in rabbit eyes","volume":"6","author":"Peng","year":"2011","journal-title":"Plos One"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706113004820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706113004820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T13:24:02Z","timestamp":1539350642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706113004820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1742706113004820"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2013.09.022","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained release of triamcinolone acetonide from an episcleral plaque of multilayered poly-\u03b5-caprolactone matrix","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2013.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}